Seoul Pharma Co. Ltd Tangible Net Worth Ratio
Seoul Pharma Co. Ltd tangible net worth ratio. Seoul Pharma Co. Ltd (018680) has a Tangible Net Worth Ratio of 98.0% as of September 2025. This metric is calculated by deducting intangible assets (₩817.77 Million) from net assets (₩41.30 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 018680 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Seoul Pharma Co. Ltd (2012–2024)
Tangible net worth ratio of Seoul Pharma Co. Ltd from 2012 to 2024. This chart shows how Seoul Pharma Co. Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 98.0%, reflecting net assets of ₩41.30 Billion with intangible assets of ₩817.77 Million KRW. See Seoul Pharma Co. Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Seoul Pharma Co. Ltd Tangible Net Worth Ratio by Year (2012–2024)
Seoul Pharma Co. Ltd tangible net worth ratio by year from 2012 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Seoul Pharma Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 018680 market cap overview.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 98.0% | ₩40.17 Billion | ₩809.45 Million | ₩71.62 Billion | ▲ +0.2 pp |
| 2023 | 97.8% | ₩38.56 Billion | ₩841.72 Million | ₩63.31 Billion | ▲ +0.3 pp |
| 2022 | 97.5% | ₩35.42 Billion | ₩881.35 Million | ₩62.43 Billion | ▲ +2.1 pp |
| 2021 | 95.4% | ₩18.96 Billion | ₩865.11 Million | ₩62.25 Billion | ▼ -0.7 pp |
| 2020 | 96.2% | ₩28.85 Billion | ₩1.11 Billion | ₩65.09 Billion | ▼ -0.5 pp |
| 2019 | 96.7% | ₩28.45 Billion | ₩938.62 Million | ₩70.89 Billion | ▼ -1.0 pp |
| 2018 | 97.7% | ₩50.31 Billion | ₩1.17 Billion | ₩90.57 Billion | ▲ +0.1 pp |
| 2017 | 97.6% | ₩53.86 Billion | ₩1.28 Billion | ₩86.93 Billion | ▲ +1.3 pp |
| 2016 | 96.3% | ₩42.07 Billion | ₩1.56 Billion | ₩92.54 Billion | ▲ +5.0 pp |
| 2015 | 91.3% | ₩33.53 Billion | ₩2.91 Billion | ₩82.68 Billion | ▲ +0.3 pp |
| 2014 | 91.0% | ₩31.10 Billion | ₩2.79 Billion | ₩78.98 Billion | ▼ -9.0 pp |
| 2013 | 100.0% | ₩32.25 Billion | ₩0.00 | ₩71.42 Billion | ▲ +0.0 pp |
| 2012 | 100.0% | ₩25.38 Billion | ₩0.00 | ₩60.68 Billion | — |